Kindred Biosciences (KIN) Announces FDA Approval of Mirataz for Cat Weigh Loss

May 7, 2018 7:02 AM EDT Send to a Friend
Kindred Biosciences, Inc. (NASDAQ: KIN) announced that the U.S. Food and Drug Administration's Center for Veterinary Medicine approved Mirataz ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login